Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
about
Terlipressin versus other vasoactive drugs for hepatorenal syndromeTerlipressin for hepatorenal syndromeHuman albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansionHepatorenal syndrome: Update on diagnosis and treatmentRenal failure in cirrhosis: Emerging conceptsCreatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-AnalysisHuman albumin in the management of complications of liver cirrhosisAlbumin administration in the acutely ill: what is new and where next?Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of HepatologyTreatment and management of ascites and hepatorenal syndrome: an updateSystematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Cirrhosis and its complications: evidence based treatment.Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy StudyRenal dysfunction in chronic liver disease.Renal dysfunction in patients with cirrhosis: Where do we stand?Hepatorenal syndrome: aetiology, diagnosis, and treatment.Vasopressin deficiency and vasodilatory state in end-stage liver disease.How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysisRole of human albumin in the management of complications of liver cirrhosis.Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis.Revision and update on clinical practice guideline for liver cirrhosis.Bench-to-bedside review: Vasopressin in the management of septic shockAssociation of AKI with mortality and complications in hospitalized patients with cirrhosisImproving survival in decompensated cirrhosisHepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.Hyponatremia and Hepatorenal SyndromePopulation Based Trends in the Incidence of Hospital Admission for the Diagnosis of Hepatorenal Syndrome: 1998-2011.Hepatorenal syndrome:Response to terlipressin and albumin and its determinants.Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - RevisedPredictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.Acute kidney injury in cirrhosis.
P2860
Q24188350-CF893C4C-240C-4DD4-A774-2DA4E4813941Q24200336-ABA94F55-FDBD-4888-A732-46F1857657DDQ26765249-6C41B5BB-51C5-4D0D-B1C2-EDA1A61B67EEQ26777608-3CD0D0E5-8592-41FD-A86E-BD4AF46F15EBQ26785971-62D084EB-C9B2-42DF-9954-77C721C720F5Q26795734-77D17B21-F1BB-467E-B8BF-A705EEEC64FCQ26852608-8272A6FE-F524-48BE-BDB6-FE865552BC0BQ26853626-159F179F-8BC9-4183-B4B0-FD2355B3061CQ26865028-DE9FF3C6-37D6-48B6-AEF0-7C51112B2CB3Q27000268-7FB631CD-31FE-4DAD-8F26-DE3FF064BE07Q30239846-09CD0591-06FB-4848-85FE-0ADE993BA1DBQ30251763-A7DDAEDB-FC07-429A-878B-39DE045772D3Q33594931-B5A9AB1C-225F-4658-BB0C-584275DE7BDBQ33698303-E4E3B300-54C0-46A1-90B3-A92D8A76E00FQ33805260-8D0574D7-B62B-4EB5-A35C-19AFA2717D96Q33918950-D89DC2AA-898D-4505-B0E3-F59B144281E6Q34047665-C2BC6FCA-A6BF-46BD-9AFC-F5B874F995FCQ35012890-170CA1E0-B8A2-4BC1-B999-46B8CAE7888AQ35118679-ABDBF2B0-8167-4E98-BB5D-E8C842CDFF5CQ35185107-967F2881-AD80-48FD-87EC-477ACDAAECE8Q35244409-42A6A812-923D-4F12-9C36-B51A81732D14Q35574320-84FF7400-0D72-4DE5-9BCE-F4172738FE8AQ35654104-66B19BC8-ACA0-4F2A-AA05-42517C61DCB6Q35852815-B933ADC1-0FE1-452D-A44A-81C4A8BE8A64Q35890613-11191117-68DF-4727-9B22-D28DEC18DEBAQ36070556-A3999D75-53FC-45D4-AC1B-9A608DBE6346Q36078269-B94DE63F-81AC-4A99-A9A7-A398B7D4C715Q36090423-BBE4B2F9-4095-4ADB-A3FA-4001BED7450DQ36093575-7EAD8C71-C466-41A1-9EF1-1F47D8C98641Q36400103-0EC84258-DCDB-4C2C-B361-92E8756A2436Q36515680-F620587F-3E8B-4AEB-9E7D-330E20543250Q36527179-373BEDC4-6289-42AD-8375-F67EB16E0E53Q36812531-76F506B1-9E6F-43D5-B372-D54658517D5FQ36814530-90EF2828-84A2-438C-AEE4-FB792FE0936BQ36876331-235881E0-55C9-4801-A507-07EF421460E8Q36980339-9932CD9A-EDBF-42AC-93EC-2F33429B223BQ37045780-56CB6349-58B2-4C77-B609-C968D6EC77DDQ37058079-9E912E6D-7697-4789-8C68-C0E92ED27859Q37141412-DC459797-7815-48C5-BFB4-E91E65290F55Q37323711-9CB4E40F-7C36-4D73-A502-EB3CEC77B508
P2860
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@ast
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@en
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@nl
type
label
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@ast
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@en
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@nl
prefLabel
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@ast
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@en
Terlipressin and albumin vs al ...... syndrome: a randomized study.
@nl
P2093
P50
P1433
P1476
Terlipressin and albumin vs al ...... l syndrome: a randomized study
@en
P2093
Alberto Monescillo
Aldo Torre
Carlos Terra
Fernando Díaz
Juan Rodés
Marie-Noëlle Pépin
Mónica Guevara
TAHRS Investigators
P304
P356
10.1053/J.GASTRO.2008.02.024
P407
P577
2008-02-14T00:00:00Z